Radiopraxis 2022; 15(04): E98-E109
DOI: 10.1055/a-1942-0267
CPD-Fortbildung

Radiosynoviorthese bei Hämophilie

Barbara Boddenberg-Pätzold
,
Michael Sigl-Kraetzig
,
Willm Uwe Kampen

Die Radiosynoviorthese (RSO) ist fester Bestandteil der Therapie bei Patienten mit Hämophilie mit rezidivierenden Gelenkeinblutungen. 70–90% der Patienten erleben eine verminderte Blutungsfrequenz, nachlassende Schmerzen und verbesserte Beweglichkeit. Der Artikel beschreibt die Pathomechanismen der Erkrankung und die Besonderheiten bei der RSO der zumeist noch jungen Patienten, die prätherapeutische Diagnostik, die Durchführung der RSO und die Nachsorge.



Publication History

Article published online:
01 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Srivastava A, Santagostino E, Dougall A. et al. WFH Guidelines for the Management of Hemophilia, 3rd edn. Haemophilia; 2020. DOI: 10.1111/hae.14046
  • 2 Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy. Semin Hematol 2016; 53: 10-19
  • 3 van Vulpen LFD, Thomas S, Keny SA. et al. Synovitis and synovectomy in Haemophilia. Haemophilia 2020; DOI: 10.1111/hae.14025.
  • 4 Hakobyan N, Kazarian T, Jabbar AA. et al. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood 2004; 104: 2060-2064
  • 5 Haberman B. et al. S2k-Leitlinie Synovitis bei Hämophilie 2018 https://www.awmf.org/uploads/tx_szleitlinien/086-005l_S2k_Synovitis-bei-Haemophilie_2019-07.pdf (Stand: 20.01.2022)
  • 6 Manco-Johnson MJ, Abshire TC, Shapiro AD. et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-544
  • 7 Mulder K, Llinás A. The target joint. Haemophilia 2004; 10: 152-156
  • 8 Hilgartner MW. Current treatment of hemophilic arthropathy. Curr Opin Pediatr 2002; 14: 46-49
  • 9 Oldenburg J. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. Blood 2015; 125: 2038-2044
  • 10 De la Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters. J Thromb Haemost 2011; 9: 928-935
  • 11 Manco-Johnson MJ, Nuss R, Lear J. et al. 32P Radiosynoviorthesis in children with hemophilia. J Pediatr Hematol Oncol 2002; 24: 534-539
  • 12 Kavakli K, Aydoğdu S, Omay SB. et al. Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish Haemophiliacs: Izmir experience. Haemophilia 2006; 12: 28-35
  • 13 Pasta G, Mancuso ME, Perfetto OS. et al. Radiosynoviorthesis in children with Haemophilia. Hamostaseologie 2009; 29: S62-S64
  • 14 Roosendaal G, Jansen NW, Schutgens R. et al. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia 2008; 14: 4-10
  • 15 Seuser A, Böhm P, Wermes C. Early orthopaedic challenges in Haemophilia patients and therapeutic approach. Thromb Res 2014; 134: S61-S67
  • 16 Seuser A. Hämophilie und Knorpel. Die Rolle der Bewegung [Haemophilia and cartilage-the role of movement]. Hamostaseologie 2012; 32: S52-S61
  • 17 Gabriel M, Pöppel TD, Freudenberg LS. et al. Gemeinsame Handlungsempfehlung (S1-Leitlinie) von DGN, OGNMB und SGNM. Radiosynoviorthese. Stand: 9/2019-AWMF-Registernummer 031-023 https://www.awmf.org/uploads/tx_szleitlinien/031-023l_S1_Radiosynoviorthese_2020-12.pdf (Stand: 20.01.2021)
  • 18 Martinoli C, Della Casa Alberighi O, Di Minno G. et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost 2013; 109: 1170-1179
  • 19 De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT. et al. The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with Haemophilia. Expert Rev Haematol 2018; 11: 253-261 DOI: 10.1080/17474086.2018.1435269.
  • 20 Management (PEDNET). MRI scores of ankle joints in children with Haemophilia-comparison with clinical data. Haemophilia 2005; 11: 116-122
  • 21 Tibussek D, Rademacher C, Caspers J. et al. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology 2017; 285: 223-230
  • 22 Sabet A, Strauss AC, Schmolders J. et al. Radiosynoviorthesis in haemophilic arthropathy: pathologic blood pool imaging on pre-therapeutic bone scintigraphy is not a predictor of treatment success. Eur J Nucl Med Mol Imaging 2017; 44: 461-467
  • 23 Rodriguez-Merchan EC. Radiosynovectomy in Haemophilia. Blood Rev 2019; 35: 1-6
  • 24 Atilla B, Güney-Deniz H. Musculoskeletal treatment in Haemophilia. EFORT Open Rev 2019; 4: 230-239
  • 25 Pasta G, Mancuso ME, Perfetto OS. et al. Synoviorthesis in Haemophilia patients with inhibitors. Haemophilia 2008; 14: 52-55
  • 26 Blanchette VS, Manco-Johnson MJ. Meeting unmet needs in inhibitor patients. Haemophilia 2010; 16: 46-51
  • 27 Rodriguez-Merchan EC. The hemophilic joints. J Blood Disord Transfus 2011; 2: 3
  • 28 Kampen WU, Boddenberg-Pätzold B, Fischer M. et al. The EANM guideline for radiosynoviorthesis. Eur J Nucl Med Mol Imaging 2021; DOI: 10.1007/s00259-021-05541-7.
  • 29 Silva M, Luck JVJr, Llinás A. Chronic haemophilic synovitis: The role of radiosynovectomy. Montréal: World Federation of Haemophilia. 2004
  • 30 De la Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with Haemophilia?. Haemophilia 2011; 17: e990-e998
  • 31 Mortazavi SM, Asadollahi S, Farzan M. et al. (32)P colloid radiosynovectomy in treatment of chronic haemophilic synovitis: Iran experience. Haemophilia 2007; 13: 182-188
  • 32 Thomas S, Gabriel MB, Assi PE. et al. Radioactive synovectomy with Yttrium⁹⁰ citrate in haemophilic synovitis: Brazilian experience. Haemophilia 2011; 17: e211-e216
  • 33 Hanley J, McKernan A, Creagh MD. et al. Guidelines for the management of acute joint bleeds and chronic synovitis in Haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) guideline. Haemophilia 2017; 23: 511-520
  • 34 Querol-Giner M, Pérez-Alenda S, Aguilar-Rodríguez M. et al. Effect of radiosynoviorthesis on the progression of arthropathy and haemarthrosis reduction in haemophilic patients. Haemophilia 2017; 23: e497-e503
  • 35 Ebrahimpour A, Ebrahiminasab M, Kaseb M. et al. Chromic phosphate-32 colloid radiosynovectomy for the treatment of haemophilic synovitis: A long-term follow-up study. Haemophilia 2020; 26: 136-141
  • 36 Vuorela J, Sokka T, Pukkala E. et al. Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis?. Ann Rheum Dis 2003; 62: 251-253
  • 37 Infante-Rivard C, Rivard GE, Derome F. et al. A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis. Haemophilia 2012; 18: 805-809
  • 38 Lim MY, Cheng D, Aschman D. et al. Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHN-dataset. Haemophilia 2017; 23: e160-e162
  • 39 Turkmen C, Ozturk S, Unal SN. et al. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid. Cancer Biother Radiopharm 2007; 22: 393-399
  • 40 Turkmen C, Ozturk S, Unal SN. et al. Monitoring the genotoxic effects of radiosynovectomy with Re-186 in paediatric age group undergoing therapy for haemophilic synovitis. Haemophilia 2007; 13: 57-64
  • 41 Klett R, Puille M, Matter HP. et al. Aktivitätsabtransport und Strahlenexposition durch die Radiosynoviorthese des Kniegelenkes: Einfluß unterschiedlicher Therapiemodalitäten. Zeitschrift für Rheumatologie 1999; 58: 207-212
  • 42 Klett R, Schnurbus-Duhs A, Modder G. et al. Biological dosimetry after radiosynoviorthesis with rhenium-186 sulphide and erbium-169 citrate. Nuklearmedizin 2012; 51: 17-25
  • 43 Gedik GK, Uğur O, Atilla B. et al. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 2006; 20: 183-188
  • 44 Lassmann M. Doismetry and radiation exposure of patients. In: Kampen WU, Fischer M. Local Treatment of Inflammatory Joint Diseases: Benefits and Risks. Cham: Springer International Publishing; 2015: 95-102
  • 45 Rodriguez-Merchan EC, Valentino LA. Safety of radiation exposure after radiosynovectomy in paediatric patients with Haemophilia. Haemophilia 2015; 21: 411-418
  • 46 Grmek M, Milcinski M, Fettich J. et al. Radiation exposure of Haemophiliacs after radiosynoviorthesis with 186Re colloid. Cancer Biother Radiopharm 2007; 22: 417
  • 47 Falcon de Vargas A, Fernandez-Palazzi F. Cytogenetic studies in patients with haemophilic haemarthrosis treated by 198Au, 186Rh, and 90Y radioactive synoviorthesis. J Pediatr Orthop B 2000; 9: 52-54
  • 48 Fernandez-Palazzi F, de Bosch NB, de Vargas AF. Radioactive synovectomy in haemophilic haemarthrosis. Follow-up of fifty cases. Scand J Haematol Suppl 1984; 40: 291-300
  • 49 Dunn AL, Manco-Johnson M, Busch MT. et al. Leukemia and P32 radionuclide synovectomy for haemophilic arthropathy. J Thromb Haemost 2005; 3: 1541-1542
  • 50 Turkmen C. Risk of cancer induction. Local treatment of inflammatory joint diseases. Berlin: Springer; 2015: 127-134